In targeted alpha-particle therapy, actinium-225 (Ac-225) has emerged as a prominent radionuclide due to its potential for clinical application in therapeutic settings. Ac-225 undergoes decay with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results